Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-31 @ 10:52 AM
Study NCT ID:
NCT01421212
Status:
COMPLETED
Last Update Posted:
2019-01-22
First Post:
2011-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Sponsor:
Biotest Pharmaceuticals Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-11
Start Date Type:
None
Primary Completion Date:
2002-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-18
First Submit QC Date:
None
Study First Post Date:
2011-08-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-17
Last Update Post Date:
2019-01-22
Last Update Post Date Type:
ACTUAL